For a better experience, Read this story in our App
-573.38
-169.60
+ 451.00
+ 1,908.00
+ 618.00
-573.38
-169.60
-169.60
+ 451.00
+ 451.00
+ 1,908.00
NSE-listed Balaxi Pharmaceuticals Ltd has commenced work on a formulation plant at Jadcherla in Telangana.
The facility, which is being taken up with an investment of Rs 85 crore, will help the company make a foray into the European markets.
It has roped in Spectrum Pharmatech Consultant Pvt Ltd to execute the project.
The facility will have the capacity to produce 1 billion tablets, 500 million capsules and 27 million liquid injections a year. The plant is expected to be operational by June 2024, a company statement said here.
Published on December 15, 2022
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.